Week in review: Gene therapy, presbyopia drops, lazy eye
- Posted on: Oct 2 2020
- Leave a response
This week, a gene therapy for Leber hereditary optic neuropathy gains orphan drug designation, a novel eye drop for presbyopia is cleared for phase 2 trials and a common antidepressant shows early promise for amblyopia.
Source: AAO
Posted in: Uncategorized
